Advertisement

Topics

FDA grants fast review for Roche's haemophilia drug

08:08 EDT 24 Aug 2017 | pharmaphorum

The US regulator has granted a fast review for Roche’s new haemophilia drug, emicizumab, a blockbuster hope for the company as its older drugs face competition from biosimilars. Roche’s Genentech unit said the FDA had granted a faster six-mont...

Original Article: FDA grants fast review for Roche's haemophilia drug

NEXT ARTICLE

More From BioPortfolio on "FDA grants fast review for Roche's haemophilia drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...